Woodline Partners LP Cellectis S.A. Transaction History

Woodline Partners LP

  • $11 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$2.29 - $4.08 $388,846 - $692,792
169,802 New
169,802 $389,000
Q4 2021

Feb 14, 2022
SELL
$8.01 - $12.84 $745,987 - $1.2 Million
-93,132 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$11.94 - $16.09 $1.11 Million - $1.5 Million
93,132 New
93,132 $1.17 Million

Others Institutions Holding CLLS

# of Institutions
31
Shares Held
11.2M
Call Options Held
5.9K
Put Options Held
1.4K
View Full List

About Cellectis S.A.

CLLS Quotes by TradingView
  • Ticker CLLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,510,800
  • Market Cap $88.3M
  • Description
  • Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatm...
More about CLLS
Track This Portfolio

Track Woodline Partners LP Portfolio

Follow Woodline Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email